Cryo-Cell International, Inc.
CCEL
$3.40
$0.041.19%
AMEX
| 05/31/2026 | 02/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.21% | -2.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.21% | -2.04% | |||
| Cost of Revenue | 1.22% | -72.81% | |||
| Gross Profit | 1.21% | 244.34% | |||
| SG&A Expenses | -7.86% | -8.01% | |||
| Depreciation & Amortization | 0.22% | 0.05% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.90% | -41.42% | |||
| Operating Income | 56.49% | 119.29% | |||
| Income Before Tax | 1,077.52% | 101.52% | |||
| Income Tax Expenses | 1,077.59% | 102.85% | |||
| Earnings from Continuing Operations | 1,077.49% | 101.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,077.49% | 101.23% | |||
| EBIT | 56.49% | 119.29% | |||
| EBITDA | 42.77% | 127.10% | |||
| EPS Basic | 1,086.21% | 101.22% | |||
| Normalized Basic EPS | 143.15% | 107.01% | |||
| EPS Diluted | 1,086.21% | 101.22% | |||
| Normalized Diluted EPS | 143.15% | 107.01% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.01% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||